Last reviewed · How we verify
Primary Hypogonadism due to Orchitis
Approved treatments
- Androgel · Besins Hlthcare
- Testosteron · Gulhane School of Medicine
- Anamidol
Anamidol binds to androgen receptors in the body, triggering a cascade of downstream effects that promote muscle growth and development. - Fluotestin
- Testred · Bausch Health
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Primary Hypogonadism due to Orchitis patent landscape — cliff calendar, originator estates, attackable patents
- Primary Hypogonadism due to Orchitis treatment landscape brief
- Primary Hypogonadism due to Orchitis treatment updates RSS
Frequently asked questions about Primary Hypogonadism due to Orchitis
What drugs treat Primary Hypogonadism due to Orchitis?
Tracked treatments include Androgel, Testosteron, Anamidol, Fluotestin, Testred.
What is the treatment for Primary Hypogonadism due to Orchitis?
Standard treatment for Primary Hypogonadism due to Orchitis includes Androgel, Testosteron, Anamidol, Fluotestin, Testred. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Primary Hypogonadism due to Orchitis patent cliff · Primary Hypogonadism due to Orchitis CI report
- Treatment: Androgel · Besins Hlthcare
- Treatment: Testosteron · Gulhane School of Medicine
- Treatment: Anamidol
- Treatment: Fluotestin
- Treatment: Testred · Bausch Health
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing